TY - JOUR
T1 - Syringe access, syringe sharing, and police encounters among people who inject drugs in New York city
T2 - A community-level perspective
AU - Beletsky, Leo
AU - Heller, Daliah
AU - Jenness, Samuel M.
AU - Neaigus, Alan
AU - Gelpi-Acosta, Camila
AU - Hagan, Holly
N1 - Funding Information:
The authors would like to acknowledge Elizabeth DiNenno and Isa Miles for their contributions to the NHBS study design, and the efforts of the NYC NHBS field staff for data collection. This work was supported, in part, by a cooperative agreement between the New York City Department of Health and Mental Hygiene and the Centers for Disease Control and Prevention (Grant #U62/CCU223595-03-1), and in part by award number R37 DA019829 from the National Institute of Drug Abuse (Strathdee: PI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Drug Abuse or the Centers for Disease Control and Prevention. These entities had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
PY - 2014/1
Y1 - 2014/1
N2 - Background: Injection drug user (IDU) experience and perceptions of police practices may alter syringe exchange program (SEP) use or influence risky behaviour. Previously, no community-level data had been collected to identify the prevalence or correlates of police encounters reported by IDUs in the United States. Methods: New York City IDUs recruited through respondent-driven sampling were asked about past-year police encounters and risk behaviours, as part of the National HIV Behavioural Surveillance study. Data were analysed using multiple logistic regression. Results: A majority (52%) of respondents (n=514) reported being stopped by police officers; 10% reported syringe confiscation. In multivariate modelling, IDUs reporting police stops were less likely to use SEPs consistently (adjusted odds ratio [AOR]=0.59; 95% confidence interval [CI]=0.40-0.89), and IDUs who had syringes confiscated may have been more likely to share syringes (AOR=1.76; 95% CI=0.90-3.44), though the finding did not reach statistical significance. Conclusions: Findings suggest that police encounters may influence consistent SEP use. The frequency of IDU-police encounters highlights the importance of including contextual and structural measures in infectious disease risk surveillance, and the need to develop approaches harmonizing structural policing and public health.
AB - Background: Injection drug user (IDU) experience and perceptions of police practices may alter syringe exchange program (SEP) use or influence risky behaviour. Previously, no community-level data had been collected to identify the prevalence or correlates of police encounters reported by IDUs in the United States. Methods: New York City IDUs recruited through respondent-driven sampling were asked about past-year police encounters and risk behaviours, as part of the National HIV Behavioural Surveillance study. Data were analysed using multiple logistic regression. Results: A majority (52%) of respondents (n=514) reported being stopped by police officers; 10% reported syringe confiscation. In multivariate modelling, IDUs reporting police stops were less likely to use SEPs consistently (adjusted odds ratio [AOR]=0.59; 95% confidence interval [CI]=0.40-0.89), and IDUs who had syringes confiscated may have been more likely to share syringes (AOR=1.76; 95% CI=0.90-3.44), though the finding did not reach statistical significance. Conclusions: Findings suggest that police encounters may influence consistent SEP use. The frequency of IDU-police encounters highlights the importance of including contextual and structural measures in infectious disease risk surveillance, and the need to develop approaches harmonizing structural policing and public health.
KW - Barriers
KW - Injection drug use
KW - Policing
KW - Public health surveillance
KW - Structural factors
KW - Syringe exchange programs
UR - http://www.scopus.com/inward/record.url?scp=84892991551&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892991551&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2013.06.005
DO - 10.1016/j.drugpo.2013.06.005
M3 - Article
C2 - 23916801
AN - SCOPUS:84892991551
SN - 0955-3959
VL - 25
SP - 105
EP - 111
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
IS - 1
ER -